107349-78-0

Basic information

• Product Name: Propanoic acid, 3-hydrazinyl-, 1,1-diMethylethyl ester
• Synonyms: Propanoic acid, 3-hydrazinyl-, 1,1-diMethylethyl ester
• CAS NO: 107349-78-0
• Molecular Formula: C7H16N2O2
• Molecular Weight: 160.21414
• EINECS: -0
• Mol File: 107349-78-0.mol

Chemical Properties

• Appearance: /
• CAS DataBase Reference: Propanoic acid, 3-hydrazinyl-, 1,1-diMethylethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Propanoic acid, 3-hydrazinyl-, 1,1-diMethylethyl ester(107349-78-0)
• EPA Substance Registry System: Propanoic acid, 3-hydrazinyl-, 1,1-diMethylethyl ester(107349-78-0)

Safety Data

• Hazardous Substances Data: 107349-78-0(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
Propanoic acid, 3-hydrazinyl-, 1,1-dimethylethyl ester is used as a reactant for the preparation of highly selective JAK2 inhibitors, such as BMS-911543, which are designed for the treatment of myeloproliferative neoplasms. Its unique molecular structure allows it to play a crucial role in the development of targeted therapies for various types of cancer.

Upstream product

• 1663-39-4 tert-Butyl acrylate 

Relevant articles and documents

Utility of azapeptides as major histocompatibility complex class II protein ligands for T-cell activation

Major histocompatibility complex class II (MHC II) protein binding and antigen specific activation of CD4+ "helper" T cells are demonstrated with peptides composed of the antigenic hen egg ovalbumin 325-339 peptide (OVA) substituted with azaami

Modulators of STING (Stimulator of Interferon Genes)

Compounds of the general formula (I): or a pharmaceutically acceptable salt thereof, processes for the preparation of these compounds, compositions containing these compounds, and the uses of these compounds.

Process for production of 2-pyrazolin-5-ones

A process for production of 2-pyrazolin-5-ones having the formula (I): STR1 which comprises cyclizing hydrazone derivatives having the formula (II): STR2 in the presence of a base; wherein R1, R2, R3 and R4 each represents a specific group; compounds having the formula (I) as well as compounds having the formula (II) and a process for production thereof.